Why is the LUPIN Share Price Rising?
Posted by : sachet | Mon Nov 17 2025
Click Here – Get Free Investment Predictions
Lupin share price: The share price of Lupin Ltd is currently priced at 2,054, reflecting an increase of 0.058%. Over the last month, Lupin’s share price has risen by 2.73%. In contrast, shares have increased by 5.81% in the previous month, and the company’s share price has risen by 1.67% over the last year. Lupin has achieved a profitability of 54.9% over the past five years. And has maintained its dividend payout of 26.0%. Lupin has consistently delivered robust financial performance due to its diversified product portfolio, geographic expansion, and operational efficiency. Lupin’s share price is a barometer of the company’s market strength as well as its prospects.
The stock’s recent movements highlight its sensitivity to broader market sentiment and economic shifts, which lead to a closer examination of the underlying causes. This article examines the primary reasons behind these movements, offering a deep overview of the rise in the price of Lupin’s shares. Despite this, the company maintains strong long-term fundamentals, as evidenced by an average Return on Equity (ROE) of 22.03%, and healthy growth rates in net sales and operating profit.
Key Reasons for the rise in the of LUPIN Share price
There are several reasons behind the Lupin share price increase, including the robust financial growth, positive market sentiments, regulatory improvements, and expansion plans.
Below are the reasons for the rise in the Lupin share price
- Robust Financial growth:
Lupin shares have shown robust growth in net profit over the year, demonstrating impressive growth in the company’s sales and continuing to improve its overall profitability and efficiency.
- Positive Market Sentiments
Lupin shares have shown substantial market share growth due to their strong demand expanding into new markets, a large customer base, and the launch of new products, all of which have demonstrated their growth potential. As a result, investors start investing in the particular share. Therefore, the share price naturally increases due to demand.
- Regulatory and operational improvement
Any such developments in the company’s operations, such as successful audits, new approvals, and facility expansions and improvements in legal compliance.
- Expansion plans
When a company enters into a new segment, offering high-value products, increases its production capacity, launches new product lines and improves research and development. It shows growth potential for future perspective.
Sign up with Univest to receive more investment predictions and access exclusive screeners! Click here.
LUPIN: Limited An Overview
LUPIN is a global pharmaceutical company based in Mumbai, India, that provides a wide range of medicines, including generics, complex generics, speciality medicines, and biosimilars. The company has a strong presence in the USA, India and Europe and continues to expand its operations. Their primary focus is on research and development, regulatory affairs and operational efficiency. With years of experience, Lupin has shown consistent innovation, global recognition, and robust production capabilities. The Lupin Human Welfare & Research Foundation (LHWRF) was set up in 1988. The project began with a set of rural development projects centred around 35 villages in Bharatpur District, Rajasthan. The total revenue of Lupin is approximately ₹22,192 crores, with an operating income of ₹5,277 crores, and total assets of ₹29,204 crores.
LUPIN Share: Performance Analysis
Lupin reported a Q2 FY 2025-26 revenue of ₹7047.51 crores, up 13.8% YoY, with net profit increased 70.8% to ₹1484.83 crores. For the full year FY205-2026, revenue reached ₹22903.72 crores and profit touched at ₹3306.26 crores. As of September 25, Lupin’s market capitalisation stood at ₹93,878.33 crores. Shareholding as of September 25 shows promoters holding 46.9%, with FIIs at 20.5%, DIIs at 26.6%, and public at 6.1%. In the broader market context, Lupin’s short-term performance has setting up the benchmark, with a 4.01% gain over the past week compared to the Sensex’s decline. However, the stock has underperformed over the longer term, with a year-to-year decline of 15.01% against a 6.81% increase in the Sensex.
How have Shares of Lupin performed recently?
Over the last month, the share price of Lupin has increased by 5.91%, rising from ₹1,940 to ₹2,053. The company’s share price has surged by 0.89% over the last year. The stock hit a 52-week high of ₹2,402.90 and a 52-week low of 1,795.20, with a P/E ratio of 21.76 and a dividend yield of 0.58%. The growth over the past six months is approximately 1.25%, and over the last year, it is approximately 0.94%.
Is Lupin a Good Stock to Buy?
The current high valuations suggest that the price may be highly affected by the positive news. For short-term investors, the recent profit-booking and high valuation can hurt the Lupin share price. In contrast, for long-term investors, Lupin’s strategic importance and diversified portfolio may make it a strong option. In summary, it can be said that the pharmaceutical sector is continuously rising, making it a good investment opportunity. Lupin has consistently delivered robust financial performance due to its diversified product portfolio, geographic expansion, and operational efficiency. Lupin’s share price is a barometer of the company’s market strength as well as its prospects.
Lupin’s journey from a domestically focused company to an internationally recognised pharmaceutical leader demonstrates its consistent growth in India. The company operates in over 100 countries across North America, Europe, Asia-Pacific, and Africa, so investors must consider Lupin’s share for investing in the long term.
Tap to Access Best Research Pieces
Lupin: Share Price Target
The Lupins have an average share price target of 2318.70. The consensus estimate represents an upside of 13.11% from the last price of 2050. View 19 reports from 10 analysts offering long-term price targets for Lupin Ltd. According to Wall Street analysts, the average one-year price target for Lupin is ₹2,281.88, with a low forecast of ₹1,922.03 and a high forecast of ₹ 2,757.30.
Lupin: Future Predictions By Analysts
Following the latest results, Lupin’s 35 analysts are now forecasting revenues of ₹259.3b in 2026. This represents a 4.8% improvement in revenue compared to the last 12 months. Per-share earnings are expected to accumulate 3.0% to ₹97.48. Before this earnings report, the analysts had been forecasting revenues of ₹254.5b and earnings per share (EPS) of ₹90.96 in 2026. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.
The price to the end of 2026 is expected to bring more of the same, according to analysts, with revenue forecasted to display 9.7% growth on an annualised basis. This aligns with its 10% annual growth over the past five years. Compare this with the broader industry, which analysts estimate (in aggregate) suggests will see revenue grow 11% annually, so although Lupin is expected to maintain its revenue growth rate, it’s only growing at about the rate of the wider industry.
Lupin: Analysts’ Rating
- The average 12-month price target is ₹2318.70, and the consensus rating is Hold (mix of Buy, Hold, & Sell).
- The analyst’s target range is observed between a high of ₹2,402.90 and a low of ₹ 1,795.20.
- According to some analysts, some concerns remain with a ‘Reduce’ call of ₹2256.80.
- The analyst’s sentiment is mixed; there have been recent bullish calls (ICICI, JM), but also cautious ones (Motilal Oswal, Nuvama).
What is the Right Time to Buy Lupin’s Shares?
According to analysts, Lupin’s share price is determined by market factors. The share price has decreased due to internal company factors, as discussed above. Therefore, investors must review all relevant factors before investing in Lupin. There are some factors to consider before investing in Lupin Company shares.
- Strong Fundamentals: Investors should review Lupin Company’s fundamentals before making an investment. If a company has strong fundamentals, high profitability, and effective management, then investors should consider investing in it.
- Financing Partnerships: Financing partnerships bridge the gap between customers and financial institutions, facilitating the distribution of a wide range of products and generating positive sales revenue for many consumers.
- Growth in the Technical Sector: The company is well-positioned in the electronic demat sector to deliver benefits to Lupin. This dominant sector increases demand and prices for Lupin.
- Highly Volatile: Prices are highly volatile, resulting in significant price changes that have a substantial impact on Lupin Company stock prices. Investors must review the market structure before investing in Lupin Company shares.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!
Conclusion
Lupin is a global pharmaceutical leader committed to improving lives by providing a portfolio spanning generics, speciality medicines, and biosimilars worldwide. The company’s core purpose is used to make treatments that transform hope into healing, which guides every decision and action the company undertakes. Over the last month, the share price of Lupin has increased by 5.91%, rising from ₹1,940 to ₹2,053. The company’s share price has surged by 0.89% over the last year. The stock hit a 52-week high of ₹2,402.90 and a 52-week low of 1,795.20, with a P/E ratio of 21.76 and a dividend yield of 0.58%. In summary, it can be said that the pharmaceutical sector is continuously rising, making it a good investment opportunity. Lupin has consistently delivered robust financial performance due to its diversified product portfolio, geographic expansion, and operational efficiency.
FAQs
What are the key reasons for investing in the shares of the company?
Ans. There are several reasons behind the Lupin share price increase, including the robust financial growth, positive market sentiments, regulatory improvements, and expansion plans. Lupin shares have shown strong growth in net profit over the year, demonstrating impressive growth in the company’s sales and continuing to improve its overall profitability and efficiency. As a result, investors start investing in the particular share. Therefore, the share price naturally increases due to demand.
Which markets contributed most to Lupin’s growth?
Ans. The highest demand in the Indian and Western markets primarily drove growth. North American sales accounted for 36% of global revenue, while the Indian formulation business contributed 37%, registering an 18.8% growth. New product launches, including complex generics, played a significant role in boosting sales.
What are the factors that affect the share price of Lupin?
Ans. According to analysts, Lupin’s share price is determined by market factors. The share price has decreased due to internal company factors, as discussed above. Therefore, investors must review all relevant factors before investing in Lupin. There are some factors to consider before investing in Lupin Company shares. Financing partnerships bridge the gap between customers and financial institutions, facilitating the distribution of a wide range of products and generating positive sales revenue for many consumers.
What is the market outlook for Lupin?
Ans. Analysts have reacted positively to the company’s performance, with several maintaining ‘buy’ ratings. They placed strong business momentum, a growing product pipeline, and operational leverage as key drivers for future growth. The price to the end of 2026 is expected to bring more of the same, according to analysts, with revenue forecasted to display 9.7% growth on an annualised basis. This aligns with its 10% annual growth over the past five years.
